The American Medical Association (AMA) released a statement Wednesday, August 8, urging the Department of Justice to block CVS Health’s proposed US$77 billion acquisition of insurance giant Aetna, due to concerns over potential anticompetitive practices. Others have also expressed their concern to the DOJ.
The AMA claimed the deal would increase concentration in 10 of the 34 Medicare Part D regional markets to the point where it is presumed likely to increase market power.
“CVS and Aetna … operate as rivals in some of the same markets, raising substantial concerns,” said AMA President Barbara McAneny in a statement.
McAneny said the merger would mean higher prices, less choice, and stifled innovation in pharmacy benefit manager services, health insurance, and pharmacy services.
CVS announced in a statement that it strongly disagreed with the AMA’s assessment of the deal.
“We believe that competition within each of the business segments in which we operate – pharmacy benefit management, pharmacies and insurers – is fierce and will remain so,” the company announced in a statement.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Shein Warns of Higher Costs for French Shoppers Amid EU Fee Proposal
May 22, 2025 by
CPI
DOJ Opens Antitrust Probe of Google’s AI Partnership with Character.AI
May 22, 2025 by
CPI
Google’s Unbundling Offer Puts Korean Regulators in Tight Spot
May 22, 2025 by
CPI
Justice Department and FTC Warn Common Ownership Could Breach Antitrust Law
May 22, 2025 by
CPI
South Africa Approves Canal+ MultiChoice Deal
May 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros